Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15

Background: The aim of the research is to study the human leukocyte antigen (HLA) class II allele frequencies in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated with anti-neurofascin 155 (NF155) antibodies. Methods: Thirteen anti-NF155+ and 35 anti-NF155 negative (anti-NF...

Descripción completa

Detalles Bibliográficos
Autores: Martinez-Martinez, L, Lleixa, MC, Boera-Carnicero, G, Cortese, A, Devaux, J, Siles, A, Rajabally, Y, Martinez-Pineiro, A, Carvajal, A, Pardo, J, Delmont, E, Attarian, S, Diaz-Manera, J, Callegari, I, Marchioni, E, Franciotta, D, Benedetti, L, Lauria, G, Martin, ODL, Juarez, C, Illa, I, Querol, L
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:España
Institución:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repositorio:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p6006
Acceso en línea:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6006
http://ddd.uab.cat/record/196948
Access Level:acceso abierto
Palabra clave:CIDP
Antibodies
NF155
HLA DRB1*15
id ES_74dbdfb50d375ded82afdbf3cc154eaa
oai_identifier_str oai:iibsantpau.fundanetsuite.com:p6006
network_acronym_str ES
network_name_str España
repository_id_str
spelling Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15Martinez-Martinez, LLleixa, MCBoera-Carnicero, GCortese, ADevaux, JSiles, ARajabally, YMartinez-Pineiro, ACarvajal, APardo, JDelmont, EAttarian, SDiaz-Manera, JCallegari, IMarchioni, EFranciotta, DBenedetti, LLauria, GMartin, ODLJuarez, CIlla, IQuerol, LCIDPAntibodiesNF155HLA DRB1*15Background: The aim of the research is to study the human leukocyte antigen (HLA) class II allele frequencies in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated with anti-neurofascin 155 (NF155) antibodies. Methods: Thirteen anti-NF155+ and 35 anti-NF155 negative (anti-NF155neg) CIDP patients were included in a case-control study. The frequencies of the DRB1 HLA allele were analyzed in all patients while DQ frequencies were only studied in patients sharing the DRB1*15 allele. In silico HLA-peptide binding and NF155 antigenicity, predictions were performed to analyze overlap between presented peptides and antigenic regions. Results: DRB1*15 alleles (DRB1*15: 01 and DRB1*15: 02) were present in 10 out of 13 anti-NF155+ CIDP patients and in only 5 out of 35 anti-NF155neg CIDP patients (77 vs 14%; OR = 20, CI = 4.035 to 99.13). DRB1*15 alleles appeared also in significantly higher proportions in anti-NF155+ CIDP than in normal population (77 vs 17%; OR = 16.9, CI = 4.434 to 57. 30). Seven anti-NF155+ CIDP patients (53%) and 5 anti-NF155neg CIDP patients had the DRB1*15: 01 allele (OR = 7, p = 0.009), while 3 anti-NF155+ CIDP patients and none of the anti-NF155neg CIDP patients had the DRB1*15: 02 allele (OR = 23.6, p = 0.016). In silico analysis of the NF155 peptides binding to DRB1*15 alleles showed significant overlap in the peptides presented by the 15: 01 and 15: 02 alleles, suggesting functional homology. Conclusions: DRB1*15 alleles are the first strong risk factor associated to a CIDP subset, providing additional evidence that anti-NF155+ CIDP patients constitute a differentiated disease within the CIDP syndrome.BMC2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6006http://ddd.uab.cat/record/196948Journal of NeuroinflammationISSN: 17422094reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pauinstname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)Inglésinfo:eu-repo/semantics/openAccessoai:iibsantpau.fundanetsuite.com:p60062026-06-14T12:41:47Z
dc.title.none.fl_str_mv Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15
title Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15
spellingShingle Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15
Martinez-Martinez, L
CIDP
Antibodies
NF155
HLA DRB1*15
title_short Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15
title_full Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15
title_fullStr Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15
title_full_unstemmed Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15
title_sort Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15
dc.creator.none.fl_str_mv Martinez-Martinez, L
Lleixa, MC
Boera-Carnicero, G
Cortese, A
Devaux, J
Siles, A
Rajabally, Y
Martinez-Pineiro, A
Carvajal, A
Pardo, J
Delmont, E
Attarian, S
Diaz-Manera, J
Callegari, I
Marchioni, E
Franciotta, D
Benedetti, L
Lauria, G
Martin, ODL
Juarez, C
Illa, I
Querol, L
author Martinez-Martinez, L
author_facet Martinez-Martinez, L
Lleixa, MC
Boera-Carnicero, G
Cortese, A
Devaux, J
Siles, A
Rajabally, Y
Martinez-Pineiro, A
Carvajal, A
Pardo, J
Delmont, E
Attarian, S
Diaz-Manera, J
Callegari, I
Marchioni, E
Franciotta, D
Benedetti, L
Lauria, G
Martin, ODL
Juarez, C
Illa, I
Querol, L
author_role author
author2 Lleixa, MC
Boera-Carnicero, G
Cortese, A
Devaux, J
Siles, A
Rajabally, Y
Martinez-Pineiro, A
Carvajal, A
Pardo, J
Delmont, E
Attarian, S
Diaz-Manera, J
Callegari, I
Marchioni, E
Franciotta, D
Benedetti, L
Lauria, G
Martin, ODL
Juarez, C
Illa, I
Querol, L
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv CIDP
Antibodies
NF155
HLA DRB1*15
topic CIDP
Antibodies
NF155
HLA DRB1*15
description Background: The aim of the research is to study the human leukocyte antigen (HLA) class II allele frequencies in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated with anti-neurofascin 155 (NF155) antibodies. Methods: Thirteen anti-NF155+ and 35 anti-NF155 negative (anti-NF155neg) CIDP patients were included in a case-control study. The frequencies of the DRB1 HLA allele were analyzed in all patients while DQ frequencies were only studied in patients sharing the DRB1*15 allele. In silico HLA-peptide binding and NF155 antigenicity, predictions were performed to analyze overlap between presented peptides and antigenic regions. Results: DRB1*15 alleles (DRB1*15: 01 and DRB1*15: 02) were present in 10 out of 13 anti-NF155+ CIDP patients and in only 5 out of 35 anti-NF155neg CIDP patients (77 vs 14%; OR = 20, CI = 4.035 to 99.13). DRB1*15 alleles appeared also in significantly higher proportions in anti-NF155+ CIDP than in normal population (77 vs 17%; OR = 16.9, CI = 4.434 to 57. 30). Seven anti-NF155+ CIDP patients (53%) and 5 anti-NF155neg CIDP patients had the DRB1*15: 01 allele (OR = 7, p = 0.009), while 3 anti-NF155+ CIDP patients and none of the anti-NF155neg CIDP patients had the DRB1*15: 02 allele (OR = 23.6, p = 0.016). In silico analysis of the NF155 peptides binding to DRB1*15 alleles showed significant overlap in the peptides presented by the 15: 01 and 15: 02 alleles, suggesting functional homology. Conclusions: DRB1*15 alleles are the first strong risk factor associated to a CIDP subset, providing additional evidence that anti-NF155+ CIDP patients constitute a differentiated disease within the CIDP syndrome.
publishDate 2017
dc.date.none.fl_str_mv 2017
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6006
http://ddd.uab.cat/record/196948
url https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6006
http://ddd.uab.cat/record/196948
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv BMC
publisher.none.fl_str_mv BMC
dc.source.none.fl_str_mv Journal of Neuroinflammation
ISSN: 17422094
reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
instname_str Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
reponame_str r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
collection r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869410938566737920
score 15,81155